Processa Pharmaceuticals (PCSA) Q1 2025 Earnings

Mar 20Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.18
-1.04
-0.91
-0.77

Details

Expected EPS
-0.845
Actual EPS
-0.77
Surprise EPS
0.07
Surprise Percent
+8.88%

Description

⁨Processa Pharmaceuticals⁩ (⁦PCSA⁩) has reported earnings of ⁦-0.77⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts